It was reported that on (b)(6) 2023, a 26mm amplatzer septal occluder was implanted successfully utilizing a 10 french amplatzer trevisio delivery system to treat secundum atrial septal defect with deficient aortic rim.The patient also presented with a dilated right heart.Size of the defect was determined to be 24mm via amplatzer sizing balloon measurement.On (b)(6) 2023, the patient presented with angina and dyspnea.The patient had pericardial effusion suspected to be due to device erosion.The device remained in place where implanted.Pericardiocentesis was performed, however the effusion began to progress into cardiac tamponade.The patient was taken to cardiac surgery where the amplatzer septal occluder was explanted and the atrial septal was surgically repaired.The patient was reported to be stable.
|
An event of angina, dyspnea, pericardial effusion suspected to be due to device erosion was reported.A returned device assessment could not be performed as the device was not returned for analysis.Information from field indicated that pericardiocentesis was performed, however the effusion began to progress into cardiac tamponade.The asd occluder was explanted and atrial septal was surgically repaired.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
|